Biodexa Pharmaceuticals Plc

NasdaqCM:BDRX Stock Report

Market Cap: US$3.2m

Biodexa Pharmaceuticals Plc Company Information

Biodexa Pharmaceuticals Plc's employee growth, exchange listings and data sources


Key Information

  • Name: Biodexa Pharmaceuticals Plc
  • Ticker: BDRX
  • Exchange: NasdaqCM
  • Founded: 2000
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$3.178m
  • Shares Outstanding: 4.38m
  • Website: https://www.biodexapharma.com

Number of Employees


Location

  • Biodexa Pharmaceuticals Plc
  • 1 Caspian Point
  • Caspian Way
  • Cardiff
  • South Glamorgan
  • CF10 4DQ
  • United Kingdom


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
5MP0BST (Boerse-Stuttgart)Ordinary SharesDEEURDec 2014
BDRXNasdaqCM (Nasdaq Capital Market)YesSPON ADS EACH REP 5 ORD SHS(R/S)USUSDDec 2015
5MPABST (Boerse-Stuttgart)YesSPON ADS EACH REP 5 ORD SHS(R/S)DEEURDec 2015
5MPDB (Deutsche Boerse AG)YesSPON ADS EACH REP 5 ORD SHS(R/S)DEEURDec 2015

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/04/25 00:00
End of Day Share Price 2024/04/25 00:00
Earnings2023/12/31
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.